UV-FANS allows deep air disinfection in any type of environment. Traditional cleaning methods are, often, not sufficient to ensure high levels of hygiene, which can be achieved only by the use of UV-C technology.


The UV-FLOW is used for creating UV germ protection barriers to be placed above the doors or ceilings of the premises with contamination control or even for the treatment of air upper layers in the environment and in closed premises.


UltraViolet Germicidal Irradiance for HVAC is a proven way to increase the quality of the air within a building. The implementation of UV air sterilization in a double-blind test of work environments had no effect on the quality of life for workers (no negative side effects) however, there were less illnesses. (Lancet 2003)



The use of the UV-C BOX and CABINETS offering is a leading solution in disinfecting and preserving the sterility of the tools, medical masks, devices, and even personal items like keys, shoes, laptops, and phones.

        UV–C Efficacy Against Coronavirus (COVID-19)

UV-C technology is a research validated disinfection method with a proven costs/benefits ratio, it’s ecological, and, unlike chemicals, it works against every microorganisms without creating any resistance.

  • 30+ YEARS OF R&D

    Our end to end UV-C application design process is managed in house with ongoing research driven relationships with Universities and leading institutions across the private sector.


The UV-C band eliminates bacteria, viruses, fungi, spores, molds and mites, destroying their DNA, and inhibiting their reproduction and proliferation


We offer the widest product range of UVGI Devices on the market, providing different solutions, great quality, 100% Made in Italy.


Our supply chain and applications have been battle tested across thousands of clients in Government, Healthcare, Food Industries, Water Treatment, HVAC & Public Transportatio


13 + 12 =


JAN 08, 2021   COVID-19 Public Restroom Review 

COVID-19 Public Restrooms Review

The COVID crisis is a remarkable threat to public health with incidence rates rising to shocking levels1. Economic impact estimates from this recent SARS epidemic are staggering2. This unprecedented situation, resulting from the extreme virulence of SARS-CoV-2 requires novel approaches and evidence- based solutions3.

 SARS-CoV-2 has been isolated in urine and feces4, demonstrated that the well-publicized respiratory droplet vector concept may lack not only a description of fecal oral transmission but also void of an informed perspective on risks of aerosolized excrement5.

Transmission dynamics around the human envelope for a virus, particularly SARS-CoV-2 are complex6. The restroom environment is particularly concerning, as modern flush toilets produce prodigious excrement aerosols. Previous work demonstrates that 104 to 109 bacterial microorganisms may be present per gram of human stool7 and up to 109 viral particles in similar sample sizes8 . Human vomit also may harbor viral pathogens, also in extremely high concentrations (106)9.

 Fluid dynamics analysis has demonstrated alarming results. Toilets produce aerosols during the flushing process with 40-60% measured particles rising above the toilet bowel (>100 cm) DURING the flushing cycle with continued airborne diffusion in the post flushing period (due to measures velocities of > 5 m/s)10.

There is a growing body of literature on air and surface disinfection with peer reviewed data demonstrating the utilization of continuous UVC as an option for enhanced disinfection to reduce the risk of infection 1112.

Air Hygiene Saves LivesTM through the use of continuous UVC to reduce the risk of respiratory tract infection13. SARS viridae including SARS-CoV-2 are extremely susceptible to continuous UVC, even at a high viral load1415.

We propose the utilization of continuous UVC in high traffic private, and all public restrooms through both surface decontamination and air hygiene (utilizing a Calculated ConventionTM paradigm) reducing the risk of SARS-CoV-2 infection within the restroom envelope with planned, evidence-based implementation16171819.

 Carl R. Peterson MD MS DABR

Chief Science Officer 11/20/20

1 https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html


3 A. Cohen and J. Cromwell. POPULATION HEALTH MANAGEMENT. Volume 00, Number 00, 2020

4 Xiao, F., Sun, J., Xu, Y., Li, F., Huang, X., Li, H….Zhao, J. (2020). Infectious SARS-CoV-2 in Feces of Patient with Severe

COVID-19. Emerging Infectious Diseases, 26(8), 1920-1922. https://dx.doi.org/10.3201/eid2608.200681.

5 J. Sun et al. (2020) Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient, Emerging Microbes & Infections, 9:1, 991-993, DOI: 10.1080/22221751.2020.1760144

6 Analysis of the Transmission Dynamics of COVID-19: An Open Evidence Review. Jefferson T, Spencer EA, Plüddemann A, Roberts N, Heneghan C. https://www.cebm.net/evidence-synthesis/transmission-dynamics-of-covid-19/.

7 Aerosol Sci Technol. 2013; 47(9): 1047–1057. doi: 10.1080/02786826.2013.814911

8 Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, Graham DY. Norwalk Virus Shedding After Experimental Human Infection. Emerg. Infect. Dis. 2008;14:1553–1557.

9 Caul EO. Small Round Structured Viruses: Airborne Transmission and Hospital Control. Lancet. 1994;343:1240–1242.

10 Phys. Fluids 32, 065107 (2020); https://doi.org/10.1063/5.0013318.

11 Anderson et al. Lancet 2017; 389: 805–14.

12 Yang et al. Journal of Microbiology, Immunology and Infection (2019) 52, 487e493.

13 Menzies et al. Volume 362, ISSUE 9398, P1785-1791, November 29, 2003.

 14 Darnell et al. Journal of Virological Methods 121 (2004) 85–91.

15 Heilingloh et al. Susceptibility of SARS-CoV-2 to UV Irradiation, AJIC: American Journal of Infection Control (2020), doi: https://doi.org/10.1016/j.ajic.2020.07.031.

16 https://www.cdc.gov/coronavirus/2019-ncov/community/reopen-guidance.html

17 https://www.cmmonline.com/articles/restroom-care-in-the-age-of-covid-19

18 Zakaria et al. Int J Environ Health Res. 2016 Oct-Dec;26(5-6):536-53. doi: 10.1080/09603123.2016.1217313. Epub 2016 Aug 10. PMID: 27666295.

19 Cooper et al. American Journal of Infection Control 44 (2016) 1692-4.